Compare InterveXion Therapeutics vs Proteostasis Therapeutics
Customers evaluate the quality of InterveXion Therapeutics's products using the following success metrics.
Overview
InterveXion Therapeutics is 22 yrs old and is based in United States.
InterveXion Therapeutics is a drug discovery and development company focused on antibody-based therapies for treating human disease. The company are developing monoclonal antibodies to treat substance abuse from PCP and methamphetamine.
Proteostasis Therapeutics is 17 yrs old and is based in United States.
Proteostasis Therapeutics (NASDAQ: PTI) develops disease-modifying therapeutics for diseases of protein processing. It provides clinical-stage novel small molecule therapies to treat the cause of cystic fibrosis. The company was founded in 2007 and is based in Boston, Massachusetts.
Demo Video
Leadership
Keith W. Ward (Chief Executive Officer, President)
David D Pendergast (Founder)
Funding
Investors
National Institutes of Health and BioVentures
F-Prime Capital, Sanofi-Genzyme BioVentures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because InterveXion Therapeutics has not claimed their profile.
Work for InterveXion Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for InterveXion Therapeutics?
Claim your profile now.
Information not available because Proteostasis Therapeutics has not claimed their profile.
Work for Proteostasis Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Proteostasis Therapeutics?
Claim your profile now.